Cargando…

Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study

INTRODUCTION: Different prolonged-release formulations of tacrolimus are available. To date, the pharmacokinetic (PK) profile of LCP-tacrolimus (LCPT; Envarsus(®)) has not been compared with PR-Tac (Advagraf(®)) in de novo kidney transplant recipients. These profiles will guide clinical recommendati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamar, Nassim, Cassuto, Elisabeth, Piotti, Giovanni, Govoni, Mirco, Ciurlia, Giorgia, Geraci, Silvia, Poli, Gianluigi, Nicolini, Gabriele, Mariat, Christophe, Essig, Marie, Malvezzi, Paolo, Le Meur, Yannick, Garrigue, Valerie, Del Bello, Arnaud, Rostaing, Lionel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824349/ https://www.ncbi.nlm.nih.gov/pubmed/30552587 http://dx.doi.org/10.1007/s12325-018-0855-1

Ejemplares similares

Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in de novo Kidney Transplant Patients Across Europe
por: Budde, Klemens, et al.
Publicado: (2022)

Conversion From Twice-Daily Tacrolimus to Once-Daily Extended Release Tacrolimus (LCPT): The Phase III Randomized MELT Trial
por: Bunnapradist, S, et al.
Publicado: (2013)

Boceprevir-Based Triple Antiviral Therapy for Chronic Hepatitis C Virus Infection in Kidney-Transplant Candidates
por: Mehawej, Mireille, et al.
Publicado: (2015)

Long-term results of a calcineurin inhibitor-free immunosuppression based on Thymoglobulin® and mycophenolate mofetil in elderly kidney transplant recipients
por: Kamar, Nassim, et al.
Publicado: (2008)

A prospective study in male recipients of kidney transplantation reveals divergent patterns for inhibin B and testosterone secretions
por: Hamdi, Safouane M, et al.
Publicado: (2014)

Tacrolimus Exposure Before and After a Switch From Twice-Daily Immediate-Release to Once-Daily Prolonged Release Tacrolimus: The ENVARSWITCH Study
por: Monchaud, Caroline, et al.
Publicado: (2023)

Beneficial Effect of Conversion to Belatacept in Kidney-Transplant Patients with a Low Glomerular-Filtration Rate
por: Belliere, Julie, et al.
Publicado: (2014)

Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ Transplantation
por: Del Bello, Arnaud, et al.
Publicado: (2021)

Once– versus twice–daily tacrolimus: are the formulations equivalent?
por: Ciszek, Michał
Publicado: (2013)

Unusual presentation of primary toxoplasmosis infection in a kidney-transplant patient complicated by an acute left-ventricular failure
por: Hébraud, Benjamin, et al.
Publicado: (2008)

Treatment of Chronic Hepatitis C Virus Infection in Dialysis Patients: An Update
por: Weclawiak, Hugo, et al.
Publicado: (2010)

Efficacy and safety of once daily tacrolimus compared to twice daily tacrolimus after liver transplantation
por: Bzeizi, Khalid Ibrahim, et al.
Publicado: (2021)

Treatment of large plasma volumes using specific immunoadsorption to desensitize ABO-incompatible kidney-transplant candidates
por: Rostaing, Lionel, et al.
Publicado: (2016)

Update on the clinical utility of once-daily tacrolimus in the management of transplantation
por: Posadas Salas, Maria Aurora, et al.
Publicado: (2014)

Update on the clinical utility of once-daily tacrolimus in the management of transplantation
por: Revollo, Jane
Publicado: (2015)

Tacrolimus Granules for Oral Suspension as Post-Transplant Immunosuppression in Routine Medical Practice in France: The OPTIMOD Study
por: Garaix, Florentine, et al.
Publicado: (2018)

An Association between BK Virus Replication in Bone Marrow and Cytopenia in Kidney-Transplant Recipients
por: Pambrun, Emilie, et al.
Publicado: (2014)

OSAKA Trial: A Randomized, Controlled Trial Comparing Tacrolimus QD and BD in Kidney Transplantation
por: Albano, Laetitia, et al.
Publicado: (2013)

Poor Long-Term Outcome in Second Kidney Transplantation: A Delayed Event
por: Trébern-Launay, Katy, et al.
Publicado: (2012)

Hepatitis E Virus Genotype 3 Diversity, France
por: Legrand-Abravanel, Florence, et al.
Publicado: (2009)

High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation
por: Del Bello, Arnaud, et al.
Publicado: (2018)

Steroid-Based Therapy and Risk of Infectious Complications
por: Rostaing, Lionel, et al.
Publicado: (2016)

Evaluation of Flexible Tacrolimus Drug Concentration Monitoring Approach in Patients Receiving Extended‐Release Once‐Daily Tacrolimus Tablets
por: Philosophe, Benjamin, et al.
Publicado: (2018)

Efficacy and safety of a switch from twice-daily tacrolimus to once-daily generic tacrolimus in stable liver transplant patients
por: Kim, Jong Man, et al.
Publicado: (2021)

Kinetics of plasmatic cytokines and cystatin C during and after hemodialysis in septic shock-related acute renal failure
por: Mayeur, Nicolas, et al.
Publicado: (2010)

Tacrolimus monotherapy in a patient with lupus flare using once-daily administration protocol
por: Tanaka, Hiroshi, et al.
Publicado: (2011)

Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients
por: Moes, D. J. A. R, et al.
Publicado: (2015)

Potentially serious medication errors with a new once-daily preparation of tacrolimus (Advagraf™)
por: Saif, Imran, et al.
Publicado: (2009)

Place of mTOR inhibitors in management of BKV infection after kidney transplantation
por: Jouve, Thomas, et al.
Publicado: (2016)

Induction by anti-thymocyte globulins in kidney transplantation: a review of the literature and current usage
por: Malvezzi, Paolo, et al.
Publicado: (2015)

Costimulation Blockade in Kidney Transplantation: An Update
por: Malvezzi, Paolo, et al.
Publicado: (2016)

Negative Impact of CMV and BKV Infections on Kidney-Allograft Function at 1-Year Post-Transplantation: Can it Be Changed by Modifying Immunosuppression?
por: Malvezzi, Paolo, et al.
Publicado: (2018)

AMIC@: All MIcroarray Clusterings @ once
por: Geraci, Filippo, et al.
Publicado: (2008)

Hepatitis E Virus Infection without Reactivation in Solid-Organ Transplant Recipients, France
por: Legrand-Abravanel, Florence, et al.
Publicado: (2011)

Isolated Aspergillosis Myocardial Abscesses in a Liver-Transplant Patient
por: Dang-Tran, Kim-Diêp, et al.
Publicado: (2014)

A Randomized Prospective Study Comparing Anti–T-Lymphocyte Igs to Basiliximab in Highly Sensitized Kidney Transplant Patients
por: Kamar, Nassim, et al.
Publicado: (2020)

Mortality Prediction after the First Year of Kidney Transplantation: An Observational Study on Two European Cohorts
por: Lorent, Marine, et al.
Publicado: (2016)

Validation of a Capillary Dry Blood Sample MITRA-Based Assay for the Quantitative Determination of Systemic Tacrolimus Concentrations in Transplant Recipients
por: Undre, Nasrullah, et al.
Publicado: (2021)

Effects of Converting Tacrolimus Formulation from Twice-Daily to Once-Daily in Liver Transplantation Recipients
por: Thorat, Ashok, et al.
Publicado: (2014)

Outcomes with Tacrolimus-Based Immunosuppression After Kidney Transplantation from Standard- and Extended-Criteria Donors – A Post Hoc Analysis of the Prospective OSAKA Study
por: Albano, Laetitia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fdn3vfaed2g8nuiuc1grhchl4q